Hasegawa Y - Search Results

1

Phase II study of erlotinib for previously treated patients with EGFR wild-type non-small-cell lung cancer, following EGFR mutation status reevaluation with the Scorpion Amplified Refractory Mutation System.

Morise M, Taniguchi H, Saka H, Shindoh J, Suzuki R, Kojima E, Hase T, Ando M, Kondo M, Saito H, Hasegawa Y. Morise M, et al. Among authors: hasegawa y. Mol Clin Oncol. 2014 Nov;2(6):991-996. doi: 10.3892/mco.2014.354. Epub 2014 Jul 22. Mol Clin Oncol. 2014. PMID: 25279187 Free PMC article.

2

[Manipulation, premedication, and chemoprophylaxis for fiberoptic bronchoscopy].

Watanabe A, Saka H, Hasegawa Y, Ogasawara T, Shimokata K. Watanabe A, et al. Among authors: hasegawa y. Nihon Kyobu Shikkan Gakkai Zasshi. 1992 Apr;30(4):593-7. Nihon Kyobu Shikkan Gakkai Zasshi. 1992. PMID: 1405073 Japanese.

3

Cytokine content in pleural effusion. Comparison between tuberculous and carcinomatous pleurisy.

Shimokata K, Saka H, Murate T, Hasegawa Y, Hasegawa T. Shimokata K, et al. Among authors: hasegawa t, hasegawa y. Chest. 1991 May;99(5):1103-7. doi: 10.1378/chest.99.5.1103. Chest. 1991. PMID: 1902158

4

[Survey of the state of bronchography in Japan].

Watanabe A, Saka H, Hasegawa Y, Shimokata K. Watanabe A, et al. Among authors: hasegawa y. Nihon Kyobu Shikkan Gakkai Zasshi. 1995 Feb;33(2):127-31. Nihon Kyobu Shikkan Gakkai Zasshi. 1995. PMID: 7731115 Japanese.

5

Gene transfer of herpes simplex virus type I thymidine kinase gene as a drug sensitivity gene into human lung cancer cell lines using retroviral vectors.

Hasegawa Y, Emi N, Shimokata K, Abe A, Kawabe T, Hasegawa T, Kirioka T, Saito H. Hasegawa Y, et al. Among authors: hasegawa t. Am J Respir Cell Mol Biol. 1993 Jun;8(6):655-61. doi: 10.1165/ajrcmb/8.6.655. Am J Respir Cell Mol Biol. 1993. PMID: 8391827

6

Detection of Pneumocystis carinii, Mycobacterium tuberculosis, and cytomegalovirus in human immunodeficiency virus (HIV)-infected patients with hemophilia by polymerase chain reaction of induced sputum samples.

Shimomoto H, Hasegawa Y, Takagi N, Ichiyama S, Takamatsu J, Saito H, Shimokata K. Shimomoto H, et al. Among authors: hasegawa y. Intern Med. 1995 Oct;34(10):976-81. doi: 10.2169/internalmedicine.34.976. Intern Med. 1995. PMID: 8563099 Free article.

7

Adenosine deaminase isozymes in tuberculous pleural effusion.

Shibagaki T, Hasegawa Y, Saito H, Yamori S, Shimokata K. Shibagaki T, et al. Among authors: hasegawa y. J Lab Clin Med. 1996 Apr;127(4):348-52. doi: 10.1016/s0022-2143(96)90182-1. J Lab Clin Med. 1996. PMID: 8656037

8

Combination effects of cisplatin, vinorelbine and irinotecan in non-small-cell lung cancer cell lines in vitro.

Mogi H, Hasegawa Y, Watanabe A, Nomura F, Saka H, Shimokata K. Mogi H, et al. Among authors: hasegawa y. Cancer Chemother Pharmacol. 1997;39(3):199-204. doi: 10.1007/s002800050560. Cancer Chemother Pharmacol. 1997. PMID: 8996520

9

Bystander tumoricidal effect and gap junctional communication in lung cancer cell lines.

Imaizumi K, Hasegawa Y, Kawabe T, Emi N, Saito H, Naruse K, Shimokata K. Imaizumi K, et al. Among authors: hasegawa y. Am J Respir Cell Mol Biol. 1998 Feb;18(2):205-12. doi: 10.1165/ajrcmb.18.2.2821. Am J Respir Cell Mol Biol. 1998. PMID: 9476907

10

Effect of gene transfer of tumor necrosis factor receptors into human lung carcinoma cell line.

Ohara H, Hasegawa Y, Kawabe T, Ichiyama S, Hara T, Shimono Y, Saito H, Shimokata K. Ohara H, et al. Among authors: hasegawa y. Jpn J Cancer Res. 1998 May;89(5):589-95. doi: 10.1111/j.1349-7006.1998.tb03302.x. Jpn J Cancer Res. 1998. PMID: 9685865 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,816 results

Search Page

Filters